What you can do if this affects you
On 7 January 2019 NHS England published its long-term plan for the NHS
Looking for the chance to make a difference? Find our latest opportunities here.
NASS is seeking an outstanding Programme Manager who will manage our new strategic initiative Aspiring to Excellence.
NASS knows that not everyone in the UK gets the same standard of care for their AS – that’s why we launched our new campaign Every Patient, Every Time.
Meet the winners of our 2018 Patients' Choice Awards. This is what excellence looks like.
NASS Stoke on Trent need your support to help to save their hydrotherapy pool.
Flu can be more severe in certain people, including anyone aged 65 and over and people with weakened immune systems. This would include people on biologic therapies like anti TNF or anti IL 17A, on regular steroids or taking DMARDs such as methotrexate
The patent for adalimumab, brand name Humira® has expired. New biosimilar versions of the drug are now available.
NASS CEO Dr Dale Webb targets the 8.5 year delay to diagnosis during Bone and Joint Week 2018